Search

everythinglearnresearchcommunity

for

Search:↓

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Sex hormones may affect COVID-19 severity and outcomes.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

COVID-19 may cause temporary hair loss due to the body's immune response.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Stem cell serum effectively treated hair loss caused by COVID-19.

Effective hair regrowth after COVID-19 involves psychological support, good nutrition, and hair growth treatments.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Frankincense may help treat COVID-19, but more research is needed.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.